Delphia (Usa) Inc. Sutro Biopharma, Inc. Transaction History

Delphia (Usa) Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$5.41 - $8.08 $7,341 - $10,964	1,357 Added 4.83%	29,456 $238,000
Q3 2022 Nov 14, 2022	BUY	$5.17 - $7.11 $51,488 - $70,808	9,959 Added 54.9%	28,099 $156,000
Q2 2022 Aug 15, 2022	BUY	$3.41 - $8.95 $61,857 - $162,353	18,140 New	18,140 $95,000

136

62.4M

77.1K

31.4K

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $139M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

Get notified when there are updates to the investment portfolio of Delphia (Usa) Inc., based on Form 13F filings with the SEC.

Stay updated on Delphia (Usa) Inc. with notifications on news.